Curcumin-loaded milk-derived sEVs fused with platelet membrane attenuate endothelial senescence and promote spinal cord injury recovery in diabetic mice
Source abstract
Abstract
Spinal cord injury (SCI) causes devastating neurological deficits, and cellular senescence critically contributes to the pathogenesis of various diseases. Notably, endothelial cells (ECs) senescence exerts a pivotal effect on the pathogenesis following SCI. In this study, we found that the number of senescent ECs increased by 18.87% ± 5.91%, and the disruption of the blood-spinal cord barrier (BSCB) was aggravated with an 18% increase in Evans Blue dye extravasation in diabetic mice with spinal cord injury (DM-SCI). To address this pathological process, a bioinspired nanotherapeutic platform utilizing milk-derived small extracellular vesicles with platelet membrane fusion (PM-sEVs) was developed for the targeted delivery of curcumin (Cur). In vitro , PM-sEVs-Cur effectively mitigated HG/IL-1β-induced HUVECs senescence by 54.19% ± 5.39% and increased expression of the tight junction protein ZO-1 by 4.33-fold. Mechanistically, Cur attenuated HUVECs senescence by activating the NRF2/HO-1 pathway. In vivo , platelet membrane modification enhanced the lesion targeting of sEVs. Treatment with PM-sEVs-Cur attenuated ECs senescence by 34.96% ± 6.59%, preserved BSCB integrity with a 17% reduction in Evans Blue dye extravasation, promoted axonal regeneration with a 6.36-fold increase in neurofilament expression, and improved motor function recovery with an increase of 2.4 ± 0.55 points in Basso Mouse Scale score in DM-SCI. This study highlights PM-sEVs-Cur as a promising therapeutic delivery platform for DM-SCI treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Mesenchymal stem cell research · Curcumin's Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (60)
Show source-provided references
1. Spinal-cord injury10.1016/S0140-6736(02)07603-1 ↗
2. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies10.1007/s00125-019-04985-9 ↗
3. Neurological recovery in diabetic rats following spinal cord injury10.1089/neu.1998.15.239 ↗
4. Chronic hyperglycemia before spinal cord injury increases inflammatory reaction and astrogliosis after injury: human and rat studies10.1089/neu.2019.6724 ↗
5. Acute hyperglycemia impairs functional improvement after spinal cord injury in mice and humans10.1126/scitranslmed.3009430 ↗
6. Protective role of SIRT1 in diabetic vascular dysfunction10.1161/ATVBAHA.109.185694 ↗
7. Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation10.1007/s00125-012-2749-0 ↗
8. Impact of cigarette smoke extract and hyperglycemic conditions on blood-brain barrier endothelial cells10.1186/s12987-015-0014-x ↗
9. Targeting senescent cells improves functional recovery after spinal cord injury10.1016/j.celrep.2021.109334 ↗
10. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors10.1016/j.cell.2005.02.003 ↗
11. The role of senescent cells in ageing10.1038/nature13193 ↗
12. Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing10.1002/jnr.10759 ↗
13. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment10.1093/brain/awp322 ↗
14. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury10.1089/neu.2013.3034 ↗
15. Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease10.1016/j.cellsig.2019.109485 ↗
16. Effective modulation of CNS inhibitory microenvironment using bioinspired hybrid-nanoscaffold-based therapeutic interventions
17. Kdm6a-CNN1 axis orchestrates epigenetic control of trauma-induced spinal cord microvascular endothelial cell senescence to balance neuroinflammation for improved neurological repair10.1038/s41413-024-00323-x ↗
18. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)10.1016/j.freeradbiomed.2007.05.009 ↗
19. Curcumin, inflammation, ageing and age-related diseases10.1186/1742-4933-7-1 ↗
20. The promise of slow down ageing may come from curcumin10.2174/138161210790883507 ↗
21. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease10.1080/10408398.2018.1552244 ↗
22. Curcumin can activate the Nrf2/HO-1 signaling pathway and scavenge free radicals in spinal cord injury treatment10.1177/15459683211011232 ↗
23. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders10.2147/IJN.S208332 ↗
24. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles10.1146/annurev-cellbio-101512-122326 ↗
25. Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles10.1093/nar/gky1029 ↗
26. Next generation of neurological therapeutics: native and bioengineered extracellular vesicles derived from stem cells
27. Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA10.1039/D0BM01497D ↗
28. Extracellular vesicles in nanomedicine and regenerative medicine: a review over the last decade
29. Engineering extracellular vesicles with platelet membranes fusion enhanced targeted therapeutic angiogenesis in a mouse model of myocardial ischemia reperfusion10.7150/thno.52496 ↗
30. Targeted repair of heart injury by stem cells fused with platelet nanovesicles10.1038/s41551-017-0182-x ↗
31. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy10.1016/j.biomaterials.2013.11.083 ↗
32. Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries10.1021/nn503732m ↗
33. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia10.1182/blood-2004-08-2980 ↗
34. Nanoparticle biointerfacing by platelet membrane cloaking10.1038/nature15373 ↗
35. Pretargeting and bioorthogonal click chemistry-mediated endogenous stem cell homing for heart repair10.1021/acsnano.8b05892 ↗
36. Platelet membrane nanocarriers Cascade targeting delivery system to improve myocardial remodeling post myocardial ischemia-reperfusion injury
37. Bovine milk-derived exosomes as a drug delivery vehicle for miRNA-Based therapy10.3390/ijms22031105 ↗
38. Isolation of extracellular vesicles from breast milk10.1007/978-1-4939-7253-1_28 ↗
39. Potential therapeutic effects of milk-derived exosomes on intestinal diseases10.1186/s12951-023-02176-8 ↗
40. FGF21 protects against aggravated blood-brain barrier disruption after ischemic focal stroke in diabetic db/db Male mice via cerebrovascular PPARγ activation10.3390/ijms21030824 ↗
41. SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling10.7150/thno.49054 ↗
42. Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury10.1038/s41467-019-08446-0 ↗
43. Truncated TrkB.T1-Mediated astrocyte dysfunction contributes to impaired motor function and neuropathic pain after spinal cord injury10.1523/JNEUROSCI.3353-16.2017 ↗
44. Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse10.1006/exnr.2001.7679 ↗
45. Reactive astrocytes protect tissue and preserve function after spinal cord injury10.1523/JNEUROSCI.3547-03.2004 ↗
46. Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains10.1089/neu.2006.23.635 ↗
47. TFE3, a potential therapeutic target for spinal cord injury via augmenting autophagy flux and alleviating ER stress10.7150/thno.46566 ↗
48. AMP-activated protein kinase-dependent induction of autophagy by erythropoietin protects against spinal cord injury in rats10.1111/cns.12856 ↗
49. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury10.1523/JNEUROSCI.1683-07.2007 ↗
50. Cellular senescence in acute and chronic wound repair
51. Kdm6a-CNN1 axis orchestrates epigenetic control of trauma-induced spinal cord microvascular endothelial cell senescence to balance neuroinflammation for improved neurological repair10.1038/s41413-024-00323-x ↗
52. The blood-spinal cord barrier: morphology and clinical implications10.1002/ana.22421 ↗
53. Blood-neural barrier: its diversity and coordinated cell-to-cell communication10.5483/BMBRep.2008.41.5.345 ↗
54. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features10.2174/092986707780597943 ↗
55. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs10.18632/aging.101250 ↗
56. Curcumin protects against the age-related hearing loss by attenuating apoptosis and senescence via activating Nrf2 signaling in cochlear hair cells10.1016/j.bcp.2023.115575 ↗
57. Non-coding RNA in raw and commercially processed milk and putative targets related to growth and immune-response10.1186/s12864-021-07964-w ↗
58. High-quality milk exosomes as oral drug delivery system10.1016/j.biomaterials.2021.121126 ↗
59. Milk-derived exosomes as functional nanocarriers in wound healing: mechanisms, applications, and future directions
60. Engineered extracellular vesicles as brain therapeutics10.1016/j.jconrel.2021.08.037 ↗